Jaiveer Singh Shekhawat
Stories by Jaiveer Singh Shekhawat
China’s Ascentage Pharma targets $1.8b valuation in US IPO
Ascentage, backed by Japan's Takeda, is looking to raise $149m.
US SEC approves spot bitcoin ETF options listing on NYSE
The SEC has granted approval to 11 ETFs to list and trade options tied to spot bitcoin prices on NYSE.
Chinese insurance broker Yuanbao files for US IPO amid reviving investor appetite
Zeekr's debut on the NYSE earlier this year was the first big listing by a Chinese company in the US.
Chinese hydrogen energy firm Huture to go public in $1b SPAC deal
Huture plans to trade on the Nasdaq following the merger, which is expected to be completed later this year.
Haidilao restaurant operator Super Hi’s shares surge 38% in strong US market debut
The restaurant operator had raised $52.7 million in its IPO.
Travel firm Viking Holdings eyes nearly $11b valuation in US IPO
After a two-year dry spell, US IPOs are expected to rebound in 2024.
BlackRock announces cuts of roughly 600 jobs—3% of its work force
No single team will be the focus of the cuts.
AI startup AlphaSense gets a valuation boost to $2.5b after latest funding round
The $150m series E financing was led by technology investment firm BOND.
SoftBank-backed biopharma firm Neumora Therapeutics files for US IPO
The filing comes at a time of renewed investor interest in IPOs.
SoftBank-backed Arm’s listing to breathe life into lacklustre IPO market
The market has seen several high-profile startups postpone their listing plans due to market volatility.
